Just a small prick
Mounjaro has silenced the constant thoughts about food, but accessing affordable treatment brings a different set of problems The post Just a small prick appeared first on Bylines Network.

Having unashamedly enjoyed the Harry Potter series, I read JK Rowling’s first fiction aimed at adults, The Casual Vacancy, when it was published in 2012. From it, I only remember one thing – and given the author’s distasteful statements on transsexuality, I won’t be re-reading it. Upon seeing one character, a shopkeeper, people would think about his penis, given his bulk was such that they surmised he was unable to view it himself.
I didn’t, thankfully, reach his dimensions, but by summer this year, I was getting close. At 6 foot 2 and weighing in at 118 kilograms (18.5 stone), my Body Mass Index (BMI) had quietly crept past 33. I was officially, medically obese. A photo taken of me shocked me into action: looking at it felt like catching a glimpse of a stranger who had stolen my face and inflated my body. Shortly after, a routine medical check-up confirmed a diagnosis of mild fatty liver disease – the direct consequence of carrying too much weight around the middle. My body was staging a quiet, internal protest, and if I didn’t listen to it, the consequences would be grave.
Now, I hear you say, you’re not a complete fool, surely it’s just a case of eating less and moving more. Ultimately, yes: if calories “in” are fewer than calories “out”, you’re going to lose weight. At 59, I had tried that, and failed. Before I had ever heard of the term, I was susceptible to “food noise”.
When hunger isn’t the problem
Although that sounds like a phrase, similar to “Pedic Perspiration” invented by the advertising moguls in Orwell’s novel Keep the aspidistra flying to scare the public into buying deodorants, it is actually A Thing. Defined as the intrusive, persistent and non-homeostatic thoughts about food that dominate a person’s cognitive space. Crucially, food noise has nothing to do with the physical sensation of an empty stomach or biological starvation. Instead, it is a relentless, background reward-seeking signal generated deep within the brain’s hedonic system.
Obesity and neurobiology research suggests that individuals vulnerable to food noise may experience altered responses to standard satiety signals. If you suffer from this, your brain is constantly tricked into believing it is running out of energy, sparking an obsessive mental search for the next calorie-dense hit. It is not a moral failure or a lack of willpower; it is a neurological battlefield.
And I was losing the battle.
So I decided, after research, to take the plunge; I’d seen the damage done, now it was time to take the needle, whatever Neil Young might think. So, like an estimated 7% of the UK population who have tried GLP-1 drugs, I started taking one – in my case, the most efficacious (and expensive) – Mounjaro, or, to give it its pharmaceutical moniker, tirzepatide.

Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. While older weight-loss medications only targeted one hormone pathway, Mounjaro mimics two distinct natural gut hormones that are naturally released when we eat. These molecules do more than just slow down how fast your stomach empties – they act on receptors in the hypothalamus and the brain’s limbic system, which regulate appetite and reward processing.
By stimulating both the GIP and GLP-1 pathways, Mounjaro effectively acts as a volume knob for the central nervous system. It helps the brain respond to fullness and radically dampens intrusive thoughts about food associated with food noise.
Silencing the food noise
The effect on me was little short of miraculous. I work from home; suddenly, that didn’t include hourly foraging to find something – anything – to eat. It was akin to George Melly’s freeing from his libido, which he described as being unchained from a maniac. I was unchained from the fridge, the cupboards. For once, I could eat and be satisfied until the next meal.
However, nothing comes without a cost; and for me and the vast amount of GLP-1 users in the UK, that cost is fiscal. Around 10 times more people in the UK are having to buy Mounjaro privately than are receiving it through the NHS. While the National Institute for Health and Care Excellence (NICE) has approved Mounjaro for weight loss, the public gatekeeping frameworks mean you practically have to be at death’s door to get it. In England, public access is strictly bottlenecked, limited mostly to specialist tier-3 or 4 weight management clinics for individuals with a sky-high BMI and severe comorbidities like sleep apnoea. With NHS waitlists for these clinics stretching into years, everyday people are bypassing the state system entirely.
The price of treatment
My research thankfully led me to a forum on Reddit for UK users, where a site called monj.co.uk, set up by volunteers, gave details of the latest prices and deals. This is the cost of the private market – I have to “pharmacy hop” every four weeks to make this affordable. Because online pharmacies are aggressively competing for market share, they offer steep first-order introductory discounts to lure you in. For instance, a 2.5mg starter pen can be found for around £92.00 delivered with introductory codes. However, once you become a repeat customer, those same pharmacies jack the price up to standard retail rates – often jumping by £50 to £100 per pen as your dosage increases.
To keep the price low, patients are forced into a monthly ritual of digital migration. To titrate up to the maximum 15mg dose over 12 months without ever paying full retail price, you have to buy from 12 completely different online pharmacies, continuously burning through new-patient welcome codes.
Doing this brings the annual cost down to an estimated £2,333; but it is an absolute pain. Every single month, you have to fill out a brand-new medical consultation form, wait for a new digital clinic to verify your photo ID, upload fresh pictures of your feet on a weighing scale, and wait for a completely new pharmacist to review your case file. It is a clunky, bureaucratic hoop-jumping exercise that highlights just how fragmented private chronic care is in Britain. There are potential risks, too, if changing providers means losing continuity of care or proper medical oversight.
The risks of a fragmented market
By doing what I’m doing, I hope to save the NHS tens of thousands on my health care. Not everyone can afford GLP-1 or afford it licitly. A new, potentially more powerful drug called retatrutide, or “Reta”, which isn’t yet licensed for use, is being purchased online via social media, with people injecting untested products amid reports of serious adverse reactions and one suspected drug-related death. As ever, the free market and people’s welfare do not always go hand-in-hand.
Obesity has long been treated as a moral failure; a simple lack of willpower from people who just couldn’t stop eating. But my experience of the sudden silence of food noise proves it was always a chemical battlefield. Three months in and 15 kilos down, I’m no longer classified as obese: a small weekly prick is entirely rewriting the script on how we heavyweights fight back.
Disclaimer: This article reflects personal perspectives on weight management treatment. Mounjaro is a prescription-only medication carrying potential side effects, and patients should always consult a qualified healthcare professional before initiating any medical intervention.
The post Just a small prick appeared first on Bylines Network.